Ipca Laboratories is a leading pharmaceutical company across the continents that work on its core values of quality, safety, integrity, dignity, responsibility.
Location: India, Maharashtra, Mumbai
Employees: 1001-5000
Founded date: 1949
Investors 1
| Date | Name | Website |
| 13.05.2024 | ChrysCapit... | chryscapit... |
Mentions in press and media 10
| Date | Title | Description |
| 20.02.2026 | ChrysCapital inks $159 mn control deal for Novartis India, makes open offer | The Novartis logo at a building in Rotkreuz, Switzerland | Credit: Reuters/Arnd Wiegmann Homegrown private equity firm ChrysCapital has agreed to acquire Swiss pharmaceutical major Novartis AG’s entire stake in its Mumbai-listed unit for Rs... |
| 29.05.2025 | Ipca Laboratories Q4 net profit up 14% at ₹68 crore | - |
| 10.04.2025 | Tariff Turmoil: The Pharmaceutical Industry Faces a Storm | The pharmaceutical industry is in the eye of a storm. President Donald Trump has thrown a wrench into the works with his proposed tariffs on drug imports. The news sent shockwaves through global markets, causing shares of major pharmaceutic... |
| 10.04.2025 | Global pharma shares plunge as Trump doubles down on tariff threat | Global drugmakers' stocks dropped across the board after US President Donald Trump reiterated plans for a "major" tariff on pharmaceutical imports, threatening an interwoven global supply chain, and as his country-specific recipro... |
| 29.05.2024 | Health secy highlights India's achievements, future goals at WHO assembly | - |
| 21.05.2024 | Expect formulations biz to outpace API biz: Biocon Group CEO Peter Bains | - |
| 08.05.2024 | Dr Reddy's Labs slumps 5% as brokerages give 'Reduce' call post Q4 earnings | - |
| 01.05.2024 | Mizoram sees alarming surge in TB deaths, 108 succumb to disease in 2023 | - |
| 02.08.2023 | Ipca picks up 33.38% equity in Unichem for ₹945 crore | Ipca Laboratories said it has picked up 33.38 percent shares from one of Unichem Laboratories’ promoters, for ₹945 crore. This follows the recent approval from the Competition Commission of India, Ipca told the stock exchanges. In April, Ip... |
| 07.12.2011 | Praxair to invest Rs 1,200 cr in India; make Bangalore hub for global pharma industry | US-based industrial gas company Praxair plans to invest about Rs 1,200 crore over the next two years in its Indian operations. It has also set up a new research and development lab here. Mr Raymond P. Roberge, Senior Vice-President and Chie... |